Correction to: A Multi-center, Open-Label, Single-Arm Trial to Evaluate the Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency.
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Authors
Description
Keywords
32 Biomedical and Clinical Sciences, 3202 Clinical Sciences
Is Part Of
Publisher
Springer Science and Business Media LLC
